Structured Summary
Abstract
An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
See Also
MeSH Record
Synonyms
17 entry terms
- Campath
- Campath 1G
- Campath 1H
- Campath 1M
- Campath-1-G
- Campath-1G
- Campath-1H
- Campath-1M
- Lemtrada
- MabCambath
- Monoclonal Antibody Campath-1H
- Antibody Campath-1H, Monoclonal
- Campath 1 G
- Campath-1H, Monoclonal Antibody
- Campath1G
- Campath1H
- Monoclonal Antibody Campath 1H
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2018 (1995)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Alemtuzumab. Medical Subject Headings (MeSH). 2026. Unique ID D000074323. http://id.nlm.nih.gov/mesh/2026/D000074323
- Alemtuzumab. In: Wikipedia. https://en.wikipedia.org/wiki/Alemtuzumab
- Alemtuzumab. In: Wikidata. https://www.wikidata.org/wiki/Q420164